company’s patented device (#9,408,672), which aims to automate the process of surgical incisions and closures. The MIPS program supports the development and commercialization of products and processes in Maryland through industry/university research partnerships. MIPS provides funds, matched by participating companies, to fund the research. After successfully completing Phase I, BondTrue plans to refine developed prototype designs, which will be used in research and testing.